Biography

Download Curriculum Vitae

Ralph DeBerardinis earned a B.S. in biology from St. Joseph’s University and M.D. and Ph.D. degrees from the University of Pennsylvania. Dr. DeBerardinis was the first trainee in the combined residency program in pediatrics and medical genetics at The Children’s Hospital of Philadelphia (CHOP) and received several awards for teaching and clinical care. He ultimately achieved board certification in pediatrics, medical genetics and clinical biochemical genetics.

Dr. DeBerardinis performed postdoctoral research in Craig Thompson’s laboratory in the Penn Cancer Center from 2004 to 2007. He joined the faculty of the University of Texas Southwestern Medical Center in 2008 and joined the Children’s Medical Center Research Institute at UT Southwestern (CRI) shortly after its founding in 2012. Dr. DeBerardinis serves as chief of Pediatric Genetics and Metabolism at UT Southwestern and director of the Genetic and Metabolic Disease Program in the CRI. Dr. DeBerardinis became a Howard Hughes Medical Institute (HHMI) Investigator in 2018 and was elected to the National Academy of Medicine in 2020.  

The DeBerardinis laboratory is interested in the role of altered metabolic states in human diseases, particularly pediatric inborn errors of metabolism and cancer. This research is tightly integrated with clinical activities in medical genetics, oncology and radiology, providing seamless opportunities to examine the relevance of findings in patients.

DeBerardinis Laboratory

Education

Medical School
University of Pennsylvania School of Medicine (2000)
Residency
Children's Hospital of Philadelphia (2005), Pediatrics & Medical Genetics

Research Interest

  • Cancer
  • Genetic disorders in children
  • Inborn errors of metabolism
  • Metabolism

Publications

Featured Publications LegendFeatured Publications

Mechanisms and Implications of Metabolic Heterogeneity in Cancer.
Kim J, DeBerardinis RJ, Cell Metab. 2019 Sep 30 3 434-446
Functional Assessment of Lipoyltransferase-1 Deficiency in Cells, Mice, and Humans.
Ni M, Solmonson A, Pan C, Yang C, Li D, Notzon A, Cai L, Guevara G, Zacharias LG, Faubert B, Vu HS, Jiang L, Ko B, Morales NM, Pei J, Vale G, Rakheja D, Grishin NV, McDonald JG, Gotway GK, McNutt MC, Pascual JM, DeBerardinis RJ, Cell Rep 2019 Apr 27 5 1376-1386.e6
Isotope Tracing of Human Clear Cell Renal Cell Carcinomas Demonstrates Suppressed Glucose Oxidation In Vivo.
Courtney KD, Bezwada D, Mashimo T, Pichumani K, Vemireddy V, Funk AM, Wimberly J, McNeil SS, Kapur P, Lotan Y, Margulis V, Cadeddu JA, Pedrosa I, DeBerardinis RJ, Malloy CR, Bachoo RM, Maher EA Cell Metab. 2018 Aug

Honors & Awards

  • National Academy of Medicine
    (2020)
  • Best Pediatric Specialists/Doctors in Dallas
    D Magazine (2016) (2018)
  • Howard Hughes Medical Institute Investigator
    (2018)
  • Howard Hughes Medical Institute Faculty Scholar
    (2017)
  • NCI Outstanding Investigator
    (2017)
  • Robert L. Moody, Sr. Faculty Scholar
    (2017)
  • Damon Runyon Cancer Research Foundation Clinical Investigator Award
    (2011)
  • President’s Research Council Distinguished Young Researcher Award
    (2008)
  • Soc. for Inherited Metabolic Disorders Neil Buist Award
    (2008)
  • Sowell Family Scholar in Medical Research
    (2008)
  • William K. Bowes, Jr. Award in Medical Genetics
    (2008)
  • CHOP Pediatric Scholars Program & Faculty Honor Roll
    (2007)
  • American Society for Clinical Investigation

Professional Associations/Affiliations

  • Investigator, Howard Hughes Medical Institute (2018)
  • American Society for Clinical Investigation (2013)
  • American Academy of Pediatrics
  • American Association for Cancer Research
  • American Society of Human Genetics
  • Society for Inherited Metabolic Disorders
  • Society for Pediatrics Research